1. Home
  2. CELH vs RGEN Comparison

CELH vs RGEN Comparison

Compare CELH & RGEN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • CELH
  • RGEN
  • Stock Information
  • Founded
  • CELH 2004
  • RGEN 1981
  • Country
  • CELH United States
  • RGEN United States
  • Employees
  • CELH N/A
  • RGEN N/A
  • Industry
  • CELH Beverages (Production/Distribution)
  • RGEN Medical/Dental Instruments
  • Sector
  • CELH Consumer Staples
  • RGEN Health Care
  • Exchange
  • CELH Nasdaq
  • RGEN Nasdaq
  • Market Cap
  • CELH 7.5B
  • RGEN 8.0B
  • IPO Year
  • CELH N/A
  • RGEN N/A
  • Fundamental
  • Price
  • CELH $39.39
  • RGEN $128.01
  • Analyst Decision
  • CELH Buy
  • RGEN Buy
  • Analyst Count
  • CELH 17
  • RGEN 12
  • Target Price
  • CELH $47.41
  • RGEN $172.67
  • AVG Volume (30 Days)
  • CELH 6.9M
  • RGEN 847.4K
  • Earning Date
  • CELH 05-06-2025
  • RGEN 04-29-2025
  • Dividend Yield
  • CELH N/A
  • RGEN N/A
  • EPS Growth
  • CELH N/A
  • RGEN N/A
  • EPS
  • CELH 0.32
  • RGEN N/A
  • Revenue
  • CELH $1,329,198,000.00
  • RGEN $650,429,000.00
  • Revenue This Year
  • CELH $42.37
  • RGEN $13.93
  • Revenue Next Year
  • CELH $17.56
  • RGEN $14.35
  • P/E Ratio
  • CELH $116.77
  • RGEN N/A
  • Revenue Growth
  • CELH N/A
  • RGEN 4.88
  • 52 Week Low
  • CELH $21.10
  • RGEN $102.97
  • 52 Week High
  • CELH $98.85
  • RGEN $182.52
  • Technical
  • Relative Strength Index (RSI)
  • CELH 66.76
  • RGEN 45.14
  • Support Level
  • CELH $32.36
  • RGEN $123.10
  • Resistance Level
  • CELH $36.16
  • RGEN $135.47
  • Average True Range (ATR)
  • CELH 1.69
  • RGEN 6.76
  • MACD
  • CELH 0.16
  • RGEN -0.72
  • Stochastic Oscillator
  • CELH 96.86
  • RGEN 20.37

About CELH Celsius Holdings Inc.

Celsius Holdings plays in the energy drink subsegment of the global nonalcoholic beverage market, with 96% of revenue concentrated in North America. Celsius' products contain natural ingredients and a metabolism-enhancing formulation, appealing to fitness and active lifestyle enthusiasts. The firm's portfolio includes its namesake Celsius Originals beverages, Celsius Essentials line (containing aminos), and Celsius On-the-Go powder packets. Celsius dedicates its efforts to branding and innovation, while it utilizes third parties for the manufacturing, packaging, and distribution of its products. In 2022, Celsius forged a 20-year distribution agreement with PepsiCo, which holds an 8.5% stake in the business.

About RGEN Repligen Corporation

Repligen, headquartered in Waltham, Massachusetts, is a global life sciences company that develops and sells bioprocessing equipment and supplies used in the manufacturing of biologic drugs, including monoclonal antibodies, recombinant proteins, vaccines, and cell and gene therapies. Its customers include biopharmaceutical companies, contract development and manufacturing organizations, or CDMOs, and other life science companies. It sells four main product categories: filtration (including fluid management) is the largest category and was 58% of 2024 revenue, while chromatography, proteins, and process analytics were 19%, 12%, and 9%, respectively. Customers in North America, Europe, and Asia Pacific contributed 44%, 37%, and 19% of revenue, respectively.

Share on Social Networks: